"The question is proportionality," said Dr. Kevin Schulman, director of the Center for Clinical and Genetic Economics at Duke University Medical Center in Durham, North Carolina, ...

Experts worry early detection tests like Galleri and CancerGuard are unproven and could drive up health care costs by ...

Medicare Part B data show that of the 20 CPT codes seeing the largest increase in payments from 2022 to 2024, all are for molecular- or sequencing-based tests.

Discover how AI-driven blood testing is revolutionizing diagnostics by offering personalized health insights and ...

The hospital system is betting the move will give it better control over turnaround time and allow it to be more "nimble" in ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its third quarter 2025 earnings conference call at 4:30 pm ET on Monday, Nov. 3, 2025.

This medical services stock is nearing a buy point. It has shown tremendous profit growth over the last few quarters.

The procedure’s punishing price tag, even for many with insurance, has led thousands of patients to try money-saving hacks.

ROLLE, Switzerland and TOKYO, Oct. 16, 2025 /PRNewswire/ -- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company ...

As more people start to opt for genetic carrier testing ahead of conception, doctors and parents-to-be are facing difficult questions and hard decisions.

Researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital (Duncan NRI) have created a new way to measure genetic variants in the ...

The Los Angeles Chargers could be without first-round rookie Omarion Hampton for a while as the team braces for injury news coming out of Week 5. Hampton exited the Chargers’ loss to the Washington ...